Science Applications International Corporation closed a $500 million offering of 6.750% Senior Notes due 2034, receiving approximately $493 million. It used the proceeds to redeem all outstanding 4.875% Senior Notes due 2028; remaining proceeds are intended for general corporate purposes.
SAIC · Science Applications International Corp
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
SAIC priced a $500 million offering of 6.75% Senior Notes due 2034, expected to close on or about November 13, 2026. Net proceeds will redeem all outstanding 4.875% Senior Notes due 2028 and pay offering fees.
Science Applications International Corporation appointed Kenneth B. Crews Executive Vice President, Chief Financial Officer effective December 7, 2026. Prabu Natarajan will lead the Civilian Business Group from October 30, 2026 and cease serving as CFO on December 7, 2026.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY27 earnings call · Aug 31, 2026TL;DR. SAIC delivered Q2 FY27 organic growth of 5.3% with 10.3% adjusted EBITDA margins and is raising full-year FY27 guidance for revenue (to $7.2B–$7.3B), adjusted EBITDA ($750M–$755M), and adjusted diluted EPS ($10.65–$10.75), while outlining Project Orbit targeting ~$150M in run-rate savings and a path to ~11% margins by FY30.
- + Raised FY27 revenue, EBITDA, and EPS guidance on strong YTD performance.
- + Adjusted EBITDA margin of 10.3% with raised FY27 margin guidance to 10.3%–10.5%.
- + Net leverage fell to 3.0x, providing capital flexibility for M&A or further deleveraging.
- + Notable new awards including a $740M DHS recompete and a $400M intelligence agency recompete.
- − Quarterly book-to-bill of 0.6 and trailing 12-month of 0.8 reflects weak bookings.
- − FY27 organic growth guide still implies contraction of 2% to flat due to RITS rolloff.
- − Adjusted diluted EPS of $3.01 was down 17% year-over-year due to prior-year settlement.
- − Second-half margins are expected to step down to high-9% range due to planned investments.
- − Slower RFPs and awards are pushing opportunities to the right and pressuring near-term book-to-bill.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted EPS non-GAAP | $6.24 | Six Months Ended July 31, 2026 | — |
| Adjusted EBITDA non-GAAP | $415M | Six Months Ended July 31, 2026 | — |
|
|
|||
| Adjusted EBITDA as a percentage of revenues non-GAAP | 11% | Six Months Ended July 31, 2026 | — |
|
|
|||
| Adjusted operating income non-GAAP | $191M | Three Months Ended July 31, 2026 filing | +4.9% |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Operating income $152M
+$7M Depreciation of property, plant and equipment
+$32M Amortization of intangible assets
+$2M Acquisition, integration, restructuring and impairment costs
-$1M Recovery of acquisition, integration, restructuring and impairment costs
+$0M Costs related to the settlement of federal tax audits
-$1M Gain on divestitures, net of transaction costs
= Adjusted operating income $191M
|
|||
| Adjusted operating income (loss) non-GAAP | $191M | the three months ended July 31, 2026 filing | — |
|
|
|||
| EBITDA non-GAAP | $413M | Six Months Ended July 31, 2026 | — |
|
|
|||
| EBITDA as a percentage of revenues non-GAAP | 10.3% | Three Months Ended July 31, 2026 filing | — |
|
|
|||
| Estimated backlog | 22.1B | Q2 FY2027 | — |
| Free cash flow non-GAAP | $249M | Six Months Ended July 31, 2026 | — |
| Funded backlog | 3.8B | Q2 FY2027 | — |
| Negotiated unfunded backlog | $18.32B | July 31, 2026 | — |
| Net bookings | 1.2B | Q2 FY2027 | — |
|
|
|||
| Organic growth non-GAAP | 5.3% | Q2 FY2027 | — |
| Quarterly book-to-bill ratio | 0.6 | Q2 FY2027 | — |
| Total adjusted operating income non-GAAP | $412M | Six Months Ended July 31, 2026 | — |
| Total adjusted operating margin non-GAAP | 10.9% | Six Months Ended July 31, 2026 | — |
| Total backlog | $22.14B | July 31, 2026 | — |
| Trailing twelve months book-to-bill ratio | 0.8 | Q2 FY2027 | — |
| Adjusted operating income (loss) - Civilian non-GAAP | 68M | the three months ended May 1, 2026 filing | — |
| Adjusted operating income (loss) - Defense and Intelligence non-GAAP | 146M | the three months ended May 1, 2026 filing | — |
| Adjusted operating income as a percentage of revenues non-GAAP | 11.6% | the three months ended May 1, 2026 filing | — |
| Revenues from contracts with the U.S. government | 97% | the three months ended May 1, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Information Technology Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SAIC
this stock
Science Applications International Corp
|
$6.16B | +46.1% | -2.9% | 17.2 | 5.0% |
|
IBM
International Business Machines Corp
|
$229.20B | -18.1% | +7.6% | 20.6 | 1.9% |
|
ACN
Accenture plc
|
$165.72B | -7.7% | +6.5% | 18.3 | 3.2% |
|
INFY
Infosys Ltd
|
$49.86B | -30.9% | — | — | 2.1% |
|
CTSH
Cognizant Technology Solutions Corp
|
$27.85B | -25.0% | +7.0% | 11.4 | 5.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 13, 2026
- This year
- 22
Science Applications International Corporation closed a $500 million offering of 6.750% Senior Notes due 2034, receiving approximately $493 million. It used the proceeds to redeem all outstanding 4.875% Senior Notes due 2028; remaining proceeds are intended for general corporate purposes.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SAIC | -2.6% | +10.4% | +44.6% | -3.2% | +46.1% |
| SPY | -1.7% | -3.5% | -1.4% | -2.1% | +8.5% |
| vs SPY | -0.9% | +13.9% | +46.0% | -1.1% | +37.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.